ArticleScientific reports2024

Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants.

Zi-Sin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.